Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant
Authors:
- 1 August 1999
- journal article
- research article
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 21 (4) , 271-275
Abstract
In a recent study we found elevated thrombopoietin (TPO) levels along with a trend toward correlation between serum TPO and some acute phase reactants (APR) in patients with reactive thrombocytosis. ...Keywords
This publication has 18 references indexed in Scilit:
- The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non‐familial essential thrombocythaemiaBritish Journal of Haematology, 1998
- Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia VeraNew England Journal of Medicine, 1998
- CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cellsNature, 1998
- An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemiaNature Genetics, 1998
- Thrombopoietin levels in patients with primary and reactive thrombocytosisBritish Journal of Haematology, 1997
- Transgenic Mice Overexpressing Human c-mpl Ligand Exhibit Chronic Thrombocytosis and Display Enhanced Recovery From 5-Fluorouracil or Antiplatelet Serum TreatmentBlood, 1997
- Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung CancerNew England Journal of Medicine, 1997
- Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancerThe Lancet, 1996
- Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy‐induced thrombocytopeniaBritish Journal of Haematology, 1996
- Which tests are most useful to distinguish between clonal and reactive thrombocytosis?The American Journal of Medicine, 1996